The negative effects of obesity on heart, especially the electrophysiology of the heart
Source abstract
Abstract
Obesity is associated with ventricular arrhythmia and sudden cardiac death. Numerous studies have shown that obesity may have effects on the heart by affecting the ventricular re-polarisation (VR). As an effective detection method for VR the measurement of the QT interval has been extensively studied in obese patients (OP). This review aims to investigate the relationship between obesity and obesity-related diseases; including diabetes, hypertension and cardiovascular diseases (CVD). This review compares the advantages and disadvantages of different QT interval measurement methods, as well as explores the possible mechanisms of obesity leading to heart disease. Finally, it also reviews the feasibility of various weight loss methods to reverse the risk of obesity leading to heart disease is discussed.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cardiac electrophysiology and arrhythmias · Cardiovascular Function and Risk Factors · ECG Monitoring and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nephrology, The Third Affiliated Hospital, Southern Medical University
Funding
Southern Medical University · Science and Technique Program of Guangzhou · South Wisdom Valley Innovative Research Team Program · The National Natural Science Foundation of China · Guangdong Province Medical Science Research Foundation
References (100+)
Show source-provided references
1. 10.1016/S0140-6736(10)62037-510.1016/S0140-6736(10)62037-5 ↗
2. 10.1016/S0140-6736(14)60460-810.1016/S0140-6736(14)60460-8 ↗
3. 10.1161/CIRCRESAHA.116.30684210.1161/CIRCRESAHA.116.306842 ↗
4. 10.1001/archinte.1987.0037010003900810.1001/archinte.1987.00370100039008 ↗
5. 10.1016/0002-8703(88)90891-510.1016/0002-8703(88)90891-5 ↗
6. 10.1111/j.1467-789X.2005.00199.x10.1111/j.1467-789X.2005.00199.x ↗
7. 10.1186/1756-0500-7-93110.1186/1756-0500-7-931 ↗
8. 10.1161/01.CIR.6.3.37810.1161/01.CIR.6.3.378 ↗
9. 10.1016/0002-9149(93)90035-B10.1016/0002-9149(93)90035-B ↗
10. 10.1016/j.pcad.2018.04.00410.1016/j.pcad.2018.04.004 ↗
11. 10.1016/0002-8703(85)90564-210.1016/0002-8703(85)90564-2 ↗
12. 10.1016/S1056-8719(03)00008-X10.1016/S1056-8719(03)00008-X ↗
13. 10.1016/0002-9149(92)90562-D10.1016/0002-9149(92)90562-D ↗
14. Curione M, Tego A, Capoccia D, et al. Prediction of QTc length as function of BMI: a clinical tool to establish arrhythmias risk in obesity. Clin Ter. 2011;162(6):e155–159–e159.
15. 10.1136/hrt.63.6.34210.1136/hrt.63.6.342 ↗
16. 10.1136/hrt.71.6.51110.1136/hrt.71.6.511 ↗
17. 10.1016/S0735-1097(00)00962-110.1016/S0735-1097(00)00962-1 ↗
18. 10.1016/S0002-9149(98)00868-610.1016/S0002-9149(98)00868-6 ↗
19. 10.1016/j.hrthm.2013.11.01710.1016/j.hrthm.2013.11.017 ↗
20. Vardar SA, Ozturk L, Altun A, et al. Ventricular repolarization in overweight and normal weight healthy young men. Anadolu Kardiyol Derg. 2008;8(1):27–31.
21. 10.1042/CS2003001010.1042/CS20030010 ↗
22. 10.1016/j.jelectrocard.2008.07.03010.1016/j.jelectrocard.2008.07.030 ↗
23. 10.1016/j.hrthm.2007.05.02810.1016/j.hrthm.2007.05.028 ↗
24. Seyfeli E, Duru M, Kuvandik G, et al. Effect of weight loss on QTc dispersion in obese subjects. Anadolu Kardiyol Derg. 2006;6(2):126–129.
25. Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss. Int J Obes Relat Metab Disord. 1996;20(10):938–942.
26. Gupta AK, Xie B, Thakur RK, et al. Effect of weight loss on QT dispersion in obesity. Indian Heart J. 2002;54(4):399–403.
27. 10.1038/oby.2011.25510.1038/oby.2011.255 ↗
28. 10.3181/00379727-220-4435510.3181/00379727-220-44355 ↗
29. 10.1038/oby.2010.25210.1038/oby.2010.252 ↗
30. 10.1038/sj.ijo.080273310.1038/sj.ijo.0802733 ↗
31. 10.1016/j.amjcard.2016.12.03310.1016/j.amjcard.2016.12.033 ↗
32. 10.1186/s13098-017-0238-910.1186/s13098-017-0238-9 ↗
33. 10.1055/s-2006-92408310.1055/s-2006-924083 ↗
34. Takebayashi K, Aso Y, Sugita R, et al. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes. Diabetes Metab. 2002;28(2):127–132.
35. 10.1177/17418267010080040710.1177/174182670100800407 ↗
36. 10.20452/pamw.92710.20452/pamw.927 ↗
37. Bilora F, Vettore G, Barbata A, et al. Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol. 1999;45(3):193–197.
38. 10.1038/oby.2003.9310.1038/oby.2003.93 ↗
39. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, et al. The QT interval dispersion and ventricular late potential in obese women. Pol Merkur Lekarski. 2000;8(44):84–86.
40. 10.1038/sj.ijo.080323310.1038/sj.ijo.0803233 ↗
41. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, et al. [QT interval dispersion and the type of obesity in women]. Pol Arch Med Wewn. 1999;101(5):391–396.
42. 10.1210/jcem.87.5.851610.1210/jcem.87.5.8516 ↗
43. 10.1038/sj.ijo.080052110.1038/sj.ijo.0800521 ↗
44. 10.1038/sj.ijo.080022010.1038/sj.ijo.0800220 ↗
45. Olivares Lopez JL, Vazquez Olivares M, Fleta Zaragozano J, et al. [Electrocardiographic and echocardiographic findings in children with overweight and obesity]. Med Clin (Barc). 2005;125(3):93–94.
46. Daar G, Serin HI, Ede H, et al. Association between the corrected QT interval, carotid artery intima-media thickness, and hepatic steatosis in obese children. Anatol J Cardiol. 2015;16(7):524–528.
47. 10.4274/jcrpe.v2i1.2110.4274/jcrpe.v2i1.21 ↗
48. 10.1016/j.pedn.2010.08.00810.1016/j.pedn.2010.08.008 ↗
49. 10.4236/wjcd.2012.2200910.4236/wjcd.2012.22009 ↗
50. 10.1139/cjpp-2017-005410.1139/cjpp-2017-0054 ↗
51. 10.1038/oby.2001.910.1038/oby.2001.9 ↗
52. 10.3892/etm.2013.133710.3892/etm.2013.1337 ↗
53. 10.5543/tkda.2013.9068810.5543/tkda.2013.90688 ↗
54. 10.2337/diacare.29.04.06.dc05-172910.2337/diacare.29.04.06.dc05-1729 ↗
55. 10.1016/S0002-9149(01)02259-710.1016/S0002-9149(01)02259-7 ↗
56. 10.1016/S0002-9149(99)00617-710.1016/S0002-9149(99)00617-7 ↗
57. 10.1111/obr.1239010.1111/obr.12390 ↗
58. 10.20344/amp.653810.20344/amp.6538 ↗
59. 10.1016/j.hrthm.2012.08.04310.1016/j.hrthm.2012.08.043 ↗
60. 10.1093/ehjci/jew31610.1093/ehjci/jew316 ↗
61. 10.1038/oby.2004.2410.1038/oby.2004.24 ↗
62. 10.1371/journal.pone.017605810.1371/journal.pone.0176058 ↗
63. 10.1016/S0022-0736(82)80003-410.1016/S0022-0736(82)80003-4 ↗
64. 10.1016/0021-9150(92)90255-F10.1016/0021-9150(92)90255-F ↗
65. Shaw PX. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Arch Immunol Ther Exp (Warsz). 2004;52(4):225–239.
66. 10.1007/s11906-008-0029-710.1007/s11906-008-0029-7 ↗
67. 10.1016/j.biocel.2007.12.00110.1016/j.biocel.2007.12.001 ↗
68. 10.1038/372425a010.1038/372425a0 ↗
69. 10.7326/0003-4819-152-2-201001190-0000810.7326/0003-4819-152-2-201001190-00008 ↗
70. 10.1006/bbrc.1997.720510.1006/bbrc.1997.7205 ↗
71. 10.1111/j.1748-1716.2005.01502.x10.1111/j.1748-1716.2005.01502.x ↗
72. 10.1016/j.plipres.2004.03.00110.1016/j.plipres.2004.03.001 ↗
73. 10.1186/1423-0127-20-9410.1186/1423-0127-20-94 ↗
74. 10.1007/BF0317986810.1007/BF03179868 ↗
75. 10.1161/01.CIR.0000155251.03724.A510.1161/01.CIR.0000155251.03724.A5 ↗
76. 10.1055/s-2004-83055510.1055/s-2004-830555 ↗
77. 10.1161/01.CIR.102.11.129610.1161/01.CIR.102.11.1296 ↗
78. 10.1210/jc.2002-02188310.1210/jc.2002-021883 ↗
79. 10.1172/JCI4346410.1172/JCI43464 ↗
80. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–850.
81. 10.1016/j.jacc.2012.04.06310.1016/j.jacc.2012.04.063 ↗
82. 10.1161/01.RES.0000154079.20681.B910.1161/01.RES.0000154079.20681.B9 ↗
83. 10.1210/en.2010-066110.1210/en.2010-0661 ↗
84. 10.1016/j.metabol.2009.07.00910.1016/j.metabol.2009.07.009 ↗
85. 10.3109/10409238.2011.59983010.3109/10409238.2011.599830 ↗
86. 10.1016/S0140-6736(86)90111-X10.1016/S0140-6736(86)90111-X ↗
87. 10.1001/jama.1987.0340009006703510.1001/jama.1987.03400090067035 ↗
88. 10.1161/01.CIR.102.14.163410.1161/01.CIR.102.14.1634 ↗
89. 10.1210/jc.2008-253410.1210/jc.2008-2534 ↗
90. 10.1111/j.1749-6632.2010.05724.x10.1111/j.1749-6632.2010.05724.x ↗
91. Galinier M, Pathak A, Roncalli J, et al. [Obesity and cardiac failure]. Arch Mal Coeur Vaiss. 2005;98(1):39–45.
92. 10.1038/sj.bjp.070659010.1038/sj.bjp.0706590 ↗
93. 10.3389/fphys.2017.0043110.3389/fphys.2017.00431 ↗
94. 10.1111/obr.1264710.1111/obr.12647 ↗
95. 10.1007/s11695-017-2923-z10.1007/s11695-017-2923-z ↗
96. 10.1007/s11695-013-1128-310.1007/s11695-013-1128-3 ↗
97. 10.1007/s11695-016-2393-810.1007/s11695-016-2393-8 ↗
98. 10.1016/j.autneu.2009.08.00710.1016/j.autneu.2009.08.007 ↗
99. 10.1381/09608920332261868710.1381/096089203322618687 ↗
100. 10.1097/MAJ.000000000000034210.1097/MAJ.0000000000000342 ↗